Clinical Trials | November 11, 2021
LifeCell Diagnostics expands newborn screening portfolio
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
Expertise in exosomes isolation and characterization will drive innovation in this field
The Thermo Scientific Orbitrap Exploris MX enables customer success by combining high-quality data with operational simplicity
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.
Subscribe To Our Newsletter & Stay Updated
